Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients

Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal regi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:American journal of kidney diseases 2015-09, Vol.66 (3), p.469-478
Hauptverfasser: Yamamoto, Tadashi, PhD, Shoji, Shigeichi, MD, PhD, Yamakawa, Tomoyuki, MD, PhD, Wada, Atsushi, MD, PhD, Suzuki, Kazuyuki, MD, PhD, Iseki, Kunitoshi, MD, PhD, Tsubakihara, Yoshiharu, MD, PhD
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 478
container_issue 3
container_start_page 469
container_title American journal of kidney diseases
container_volume 66
creator Yamamoto, Tadashi, PhD
Shoji, Shigeichi, MD, PhD
Yamakawa, Tomoyuki, MD, PhD
Wada, Atsushi, MD, PhD
Suzuki, Kazuyuki, MD, PhD
Iseki, Kunitoshi, MD, PhD
Tsubakihara, Yoshiharu, MD, PhD
description Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal registry of the Japanese Society of Dialysis Therapy (2008-2009), including 15,132 dialysis patients 16 years or older. Predictor Predialysis pH < 7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or ≥7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level < 18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or ≥26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH < 7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or ≥7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or ≥28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). Outcomes All-cause and cardiovascular (CV) mortality during the 1-year follow-up. Measurements HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate. Results Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH ≥ 7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH < 7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH ≥ 7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause and CV mortality was observed. Limitations Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths. Conclusions Predialysis pH ≥ 7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre- and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients.
doi_str_mv 10.1053/j.ajkd.2015.04.014
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1706577547</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0272638615007052</els_id><sourcerecordid>1706577547</sourcerecordid><originalsourceid>FETCH-LOGICAL-c547t-ab6ac970b48b3db79b751ce5ef106d1498933b79007cebcc4b2f94bbc91163943</originalsourceid><addsrcrecordid>eNp9ksFu1DAURS0EokPhB1igLNkk2HFiJxJCakfAIA3qqMDasp0X5IwTD7ZTaT6g_43TKbPogpXlq3uv5fMeQm8JLgiu6YehkMO-K0pM6gJXBSbVM7QidUlz1tDmOVrhkpc5ow27QK9CGDDGLWXsJbooWcqUnK3Q_c5DZ6Q9BhMyOXXZzoV4Fg6bB-3aaOmVm2SEh_utCfvM9dmVtflazuGkrqXvjLuTQc9W-uy781FaE4-ZmbKtm37nEfyYbWB05_6djAamGF6jF720Ad48npfo15fPP9ebfHvz9dv6apvruuIxl4pJ3XKsqkbRTvFW8ZpoqKEnmHWkapuW0iRjzDUorStV9m2llG4JYbSt6CV6f-o9ePdnhhDFaIIGa-UEbg6CcMxqztNjyVqerNq7EDz04uDNKP1RECwW_GIQC36x4Be4Egl_Cr177J_VCN058o93Mnw8GSD98s6AF0EnAjrNwIOOonPm__2fnsS1NVOajt3DEcLgZj8lfoKIUAosfiwLsMyf1AkJTpvxF43ArKo</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1706577547</pqid></control><display><type>article</type><title>Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Yamamoto, Tadashi, PhD ; Shoji, Shigeichi, MD, PhD ; Yamakawa, Tomoyuki, MD, PhD ; Wada, Atsushi, MD, PhD ; Suzuki, Kazuyuki, MD, PhD ; Iseki, Kunitoshi, MD, PhD ; Tsubakihara, Yoshiharu, MD, PhD</creator><creatorcontrib>Yamamoto, Tadashi, PhD ; Shoji, Shigeichi, MD, PhD ; Yamakawa, Tomoyuki, MD, PhD ; Wada, Atsushi, MD, PhD ; Suzuki, Kazuyuki, MD, PhD ; Iseki, Kunitoshi, MD, PhD ; Tsubakihara, Yoshiharu, MD, PhD</creatorcontrib><description><![CDATA[Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal registry of the Japanese Society of Dialysis Therapy (2008-2009), including 15,132 dialysis patients 16 years or older. Predictor Predialysis pH < 7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or ≥7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level < 18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or ≥26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH < 7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or ≥7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or ≥28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). Outcomes All-cause and cardiovascular (CV) mortality during the 1-year follow-up. Measurements HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate. Results Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH ≥ 7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH < 7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH ≥ 7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause and CV mortality was observed. Limitations Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths. Conclusions Predialysis pH ≥ 7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre- and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients.]]></description><identifier>ISSN: 0272-6386</identifier><identifier>EISSN: 1523-6838</identifier><identifier>DOI: 10.1053/j.ajkd.2015.04.014</identifier><identifier>PMID: 26015276</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>acid-base status ; Aged ; all-cause mortality ; Cardiovascular Diseases - mortality ; cardiovascular mortality ; Cause of Death ; dialysate bicarbonate ; end-stage renal disease (ESRD) ; Female ; hemodialysis ; Humans ; Hydrogen-Ion Concentration ; Japanese Renal Data Registry (JRDR) ; Kidney Failure, Chronic - mortality ; Kidney Failure, Chronic - therapy ; Male ; metabolic acidosis ; Middle Aged ; Multivariate Analysis ; Nephrology ; postdialysis pH ; Predialysis pH ; Renal Dialysis - mortality ; renal replacement therapy ; Risk Assessment ; serum bicarbonate ; Sodium Bicarbonate - blood</subject><ispartof>American journal of kidney diseases, 2015-09, Vol.66 (3), p.469-478</ispartof><rights>National Kidney Foundation, Inc.</rights><rights>2015 National Kidney Foundation, Inc.</rights><rights>Copyright © 2015 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c547t-ab6ac970b48b3db79b751ce5ef106d1498933b79007cebcc4b2f94bbc91163943</citedby><cites>FETCH-LOGICAL-c547t-ab6ac970b48b3db79b751ce5ef106d1498933b79007cebcc4b2f94bbc91163943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0272638615007052$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26015276$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yamamoto, Tadashi, PhD</creatorcontrib><creatorcontrib>Shoji, Shigeichi, MD, PhD</creatorcontrib><creatorcontrib>Yamakawa, Tomoyuki, MD, PhD</creatorcontrib><creatorcontrib>Wada, Atsushi, MD, PhD</creatorcontrib><creatorcontrib>Suzuki, Kazuyuki, MD, PhD</creatorcontrib><creatorcontrib>Iseki, Kunitoshi, MD, PhD</creatorcontrib><creatorcontrib>Tsubakihara, Yoshiharu, MD, PhD</creatorcontrib><title>Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients</title><title>American journal of kidney diseases</title><addtitle>Am J Kidney Dis</addtitle><description><![CDATA[Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal registry of the Japanese Society of Dialysis Therapy (2008-2009), including 15,132 dialysis patients 16 years or older. Predictor Predialysis pH < 7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or ≥7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level < 18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or ≥26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH < 7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or ≥7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or ≥28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). Outcomes All-cause and cardiovascular (CV) mortality during the 1-year follow-up. Measurements HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate. Results Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH ≥ 7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH < 7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH ≥ 7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause and CV mortality was observed. Limitations Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths. Conclusions Predialysis pH ≥ 7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre- and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients.]]></description><subject>acid-base status</subject><subject>Aged</subject><subject>all-cause mortality</subject><subject>Cardiovascular Diseases - mortality</subject><subject>cardiovascular mortality</subject><subject>Cause of Death</subject><subject>dialysate bicarbonate</subject><subject>end-stage renal disease (ESRD)</subject><subject>Female</subject><subject>hemodialysis</subject><subject>Humans</subject><subject>Hydrogen-Ion Concentration</subject><subject>Japanese Renal Data Registry (JRDR)</subject><subject>Kidney Failure, Chronic - mortality</subject><subject>Kidney Failure, Chronic - therapy</subject><subject>Male</subject><subject>metabolic acidosis</subject><subject>Middle Aged</subject><subject>Multivariate Analysis</subject><subject>Nephrology</subject><subject>postdialysis pH</subject><subject>Predialysis pH</subject><subject>Renal Dialysis - mortality</subject><subject>renal replacement therapy</subject><subject>Risk Assessment</subject><subject>serum bicarbonate</subject><subject>Sodium Bicarbonate - blood</subject><issn>0272-6386</issn><issn>1523-6838</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9ksFu1DAURS0EokPhB1igLNkk2HFiJxJCakfAIA3qqMDasp0X5IwTD7ZTaT6g_43TKbPogpXlq3uv5fMeQm8JLgiu6YehkMO-K0pM6gJXBSbVM7QidUlz1tDmOVrhkpc5ow27QK9CGDDGLWXsJbooWcqUnK3Q_c5DZ6Q9BhMyOXXZzoV4Fg6bB-3aaOmVm2SEh_utCfvM9dmVtflazuGkrqXvjLuTQc9W-uy781FaE4-ZmbKtm37nEfyYbWB05_6djAamGF6jF720Ad48npfo15fPP9ebfHvz9dv6apvruuIxl4pJ3XKsqkbRTvFW8ZpoqKEnmHWkapuW0iRjzDUorStV9m2llG4JYbSt6CV6f-o9ePdnhhDFaIIGa-UEbg6CcMxqztNjyVqerNq7EDz04uDNKP1RECwW_GIQC36x4Be4Egl_Cr177J_VCN058o93Mnw8GSD98s6AF0EnAjrNwIOOonPm__2fnsS1NVOajt3DEcLgZj8lfoKIUAosfiwLsMyf1AkJTpvxF43ArKo</recordid><startdate>20150901</startdate><enddate>20150901</enddate><creator>Yamamoto, Tadashi, PhD</creator><creator>Shoji, Shigeichi, MD, PhD</creator><creator>Yamakawa, Tomoyuki, MD, PhD</creator><creator>Wada, Atsushi, MD, PhD</creator><creator>Suzuki, Kazuyuki, MD, PhD</creator><creator>Iseki, Kunitoshi, MD, PhD</creator><creator>Tsubakihara, Yoshiharu, MD, PhD</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20150901</creationdate><title>Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients</title><author>Yamamoto, Tadashi, PhD ; Shoji, Shigeichi, MD, PhD ; Yamakawa, Tomoyuki, MD, PhD ; Wada, Atsushi, MD, PhD ; Suzuki, Kazuyuki, MD, PhD ; Iseki, Kunitoshi, MD, PhD ; Tsubakihara, Yoshiharu, MD, PhD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c547t-ab6ac970b48b3db79b751ce5ef106d1498933b79007cebcc4b2f94bbc91163943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>acid-base status</topic><topic>Aged</topic><topic>all-cause mortality</topic><topic>Cardiovascular Diseases - mortality</topic><topic>cardiovascular mortality</topic><topic>Cause of Death</topic><topic>dialysate bicarbonate</topic><topic>end-stage renal disease (ESRD)</topic><topic>Female</topic><topic>hemodialysis</topic><topic>Humans</topic><topic>Hydrogen-Ion Concentration</topic><topic>Japanese Renal Data Registry (JRDR)</topic><topic>Kidney Failure, Chronic - mortality</topic><topic>Kidney Failure, Chronic - therapy</topic><topic>Male</topic><topic>metabolic acidosis</topic><topic>Middle Aged</topic><topic>Multivariate Analysis</topic><topic>Nephrology</topic><topic>postdialysis pH</topic><topic>Predialysis pH</topic><topic>Renal Dialysis - mortality</topic><topic>renal replacement therapy</topic><topic>Risk Assessment</topic><topic>serum bicarbonate</topic><topic>Sodium Bicarbonate - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yamamoto, Tadashi, PhD</creatorcontrib><creatorcontrib>Shoji, Shigeichi, MD, PhD</creatorcontrib><creatorcontrib>Yamakawa, Tomoyuki, MD, PhD</creatorcontrib><creatorcontrib>Wada, Atsushi, MD, PhD</creatorcontrib><creatorcontrib>Suzuki, Kazuyuki, MD, PhD</creatorcontrib><creatorcontrib>Iseki, Kunitoshi, MD, PhD</creatorcontrib><creatorcontrib>Tsubakihara, Yoshiharu, MD, PhD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>American journal of kidney diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yamamoto, Tadashi, PhD</au><au>Shoji, Shigeichi, MD, PhD</au><au>Yamakawa, Tomoyuki, MD, PhD</au><au>Wada, Atsushi, MD, PhD</au><au>Suzuki, Kazuyuki, MD, PhD</au><au>Iseki, Kunitoshi, MD, PhD</au><au>Tsubakihara, Yoshiharu, MD, PhD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients</atitle><jtitle>American journal of kidney diseases</jtitle><addtitle>Am J Kidney Dis</addtitle><date>2015-09-01</date><risdate>2015</risdate><volume>66</volume><issue>3</issue><spage>469</spage><epage>478</epage><pages>469-478</pages><issn>0272-6386</issn><eissn>1523-6838</eissn><abstract><![CDATA[Background To date, very few studies have been carried out on the associations of pre- and postdialysis acid-base parameters with mortality in hemodialysis patients. Study Design An observational study including cross-sectional and 1-year analyses. Setting & Participants Data from the renal registry of the Japanese Society of Dialysis Therapy (2008-2009), including 15,132 dialysis patients 16 years or older. Predictor Predialysis pH < 7.30, 7.30 to 7.34 (reference), 7.35 to 7.39, or ≥7.40 (1,550, 4,802, 6,023, and 2,757 patients, respectively); predialysis bicarbonate level < 18.0, 18.0 to 21.9 (reference), 22.0 to 25.9, or ≥26.0 mEq/L (2,724, 7,851, 4,023, and 534 patients, respectively); postdialysis pH < 7.40, 7.40 to 7.44, 7.45 to 7.49 (reference), or ≥7.50 (2,114, 5,331, 4,975, and 2,712 patients, respectively); and postdialysis bicarbonate level < 24.0, 24.0 to 25.9, 26.0 to 27.9 (reference), or ≥28.0 mEq/L (5,087, 4,330, 3,451, and 2,264 patients, respectively). Outcomes All-cause and cardiovascular (CV) mortality during the 1-year follow-up. Measurements HRs were estimated using unadjusted models and models adjusted for age, sex, dialysis vintage, history of CV disease, diabetes, weight gain ratio, body mass index, calcium-phosphorus product, serum albumin level, serum total cholesterol level, blood hemoglobin level, single-pool Kt/V, and normalized protein catabolic rate. Results Of 15,132 patients, during follow-up, 1,042 died of all causes, including 408 CV deaths. In the adjusted analysis for all-cause mortality, HRs compared to the reference group were significantly higher in patients with predialysis pH ≥ 7.40 (HR, 1.36; 95% CI, 1.13-1.65) and postdialysis pH < 7.40 (HR, 1.22; 95% CI, 1.00-1.49). Predialysis pH ≥ 7.40 was also associated with higher risk of CV mortality (HR, 1.34; 95% CI, 1.01-1.79). No association of pre- or postdialysis bicarbonate level with all-cause and CV mortality was observed. Limitations Single measurements of acid-base parameters, short duration of follow-up, small number of CV deaths. Conclusions Predialysis pH ≥ 7.40 was associated with significantly elevated risk of all-cause and CV mortality. However, pre- and postdialysis bicarbonate levels were not associated with all-cause and CV mortality. Predialysis pH may be the most appropriate reference for accurate correction of metabolic acidosis in dialysis patients.]]></abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>26015276</pmid><doi>10.1053/j.ajkd.2015.04.014</doi><tpages>10</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0272-6386
ispartof American journal of kidney diseases, 2015-09, Vol.66 (3), p.469-478
issn 0272-6386
1523-6838
language eng
recordid cdi_proquest_miscellaneous_1706577547
source MEDLINE; Elsevier ScienceDirect Journals
subjects acid-base status
Aged
all-cause mortality
Cardiovascular Diseases - mortality
cardiovascular mortality
Cause of Death
dialysate bicarbonate
end-stage renal disease (ESRD)
Female
hemodialysis
Humans
Hydrogen-Ion Concentration
Japanese Renal Data Registry (JRDR)
Kidney Failure, Chronic - mortality
Kidney Failure, Chronic - therapy
Male
metabolic acidosis
Middle Aged
Multivariate Analysis
Nephrology
postdialysis pH
Predialysis pH
Renal Dialysis - mortality
renal replacement therapy
Risk Assessment
serum bicarbonate
Sodium Bicarbonate - blood
title Predialysis and Postdialysis pH and Bicarbonate and Risk of All-Cause and Cardiovascular Mortality in Long-term Hemodialysis Patients
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T07%3A41%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Predialysis%20and%20Postdialysis%20pH%20and%20Bicarbonate%20and%20Risk%20of%20All-Cause%20and%20Cardiovascular%20Mortality%20in%20Long-term%20Hemodialysis%20Patients&rft.jtitle=American%20journal%20of%20kidney%20diseases&rft.au=Yamamoto,%20Tadashi,%20PhD&rft.date=2015-09-01&rft.volume=66&rft.issue=3&rft.spage=469&rft.epage=478&rft.pages=469-478&rft.issn=0272-6386&rft.eissn=1523-6838&rft_id=info:doi/10.1053/j.ajkd.2015.04.014&rft_dat=%3Cproquest_cross%3E1706577547%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1706577547&rft_id=info:pmid/26015276&rft_els_id=S0272638615007052&rfr_iscdi=true